Navidea Biopharmaceuticals, Inc.
NAVB
$0.0001
$0.000.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.86M | 6.14M | 33.80K | 2.00M | 4.60M |
| Total Receivables | 30.90K | 44.70K | 31.00K | 600.00 | 155.20K |
| Inventory | 460.70K | 460.70K | 460.60K | 427.30K | 193.80K |
| Prepaid Expenses | 146.60K | 355.20K | 672.10K | 780.10K | 150.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.50M | 7.00M | 1.20M | 3.20M | 5.10M |
|
|
|||||
| Total Current Assets | 4.50M | 7.00M | 1.20M | 3.20M | 5.10M |
| Net Property, Plant & Equipment | 119.40K | 142.00K | 147.70K | 155.60K | 185.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.06M | 1.06M | 1.01M | 1.00M | 941.20K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.80K | 11.80K | 11.80K | 11.80K | 31.80K |
| Total Assets | 5.70M | 8.22M | 2.37M | 4.37M | 6.26M |
|
|
|||||
| Total Accounts Payable | 2.07M | 2.01M | 3.17M | 2.12M | 1.74M |
| Total Accrued Expenses | 3.39M | 3.72M | 4.32M | 6.46M | 5.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.26M | 1.34M | 353.40K | 562.60K | 27.30K |
| Total Finance Division Other Current Liabilities | 1.26M | 1.24M | 1.41M | 801.60K | 1.60M |
| Total Other Current Liabilities | 1.26M | 1.24M | 1.41M | 801.60K | 1.60M |
| Total Current Liabilities | 7.98M | 8.31M | 9.25M | 9.94M | 8.43M |
|
|
|||||
| Total Current Liabilities | 7.98M | 8.31M | 9.25M | 9.94M | 8.43M |
| Long-Term Debt | -- | -- | 1.96M | 1.87M | 1.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 300.00 | 500.00 | 900.00 | 1.30K | 1.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 700.00K | 700.00K | 700.00K | 700.00K | 700.00K |
| Total Liabilities | 8.68M | 9.01M | 11.92M | 12.51M | 10.93M |
|
|
|||||
| Common Stock & APIC | 382.64M | 382.57M | 379.64M | 379.57M | 379.56M |
| Retained Earnings | -385.91M | -383.65M | -389.48M | -388.00M | -384.52M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.27M | -1.08M | -9.84M | -8.44M | -4.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | 100.00 | -- | 0.00 | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 100.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | -3.27M | -1.08M | -9.84M | -8.44M | -4.96M |
| Total Preferred Equity | 0.00 | 100.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | 292.50K | 292.50K | 292.50K | 292.50K | 292.50K |
| Total Equity | -2.98M | -786.60K | -9.55M | -8.14M | -4.67M |
|
|
|||||
